Chomienne C - Search Results

1

A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.

Eclache V, Viguie F, Frocrain C, Cassinat B, Chomienne C, Cymbalista F, Fenaux P. Eclache V, et al. Among authors: chomienne c. Cancer Genet Cytogenet. 2005 May;159(1):69-73. doi: 10.1016/j.cancergencyto.2004.09.013. Cancer Genet Cytogenet. 2005. PMID: 15860361

2

Biology and treatment of acute promyelocytic leukemia.

Fenaux P, Chomienne C. Fenaux P, et al. Among authors: chomienne c. Curr Opin Oncol. 1996 Jan;8(1):3-12. doi: 10.1097/00001622-199601000-00002. Curr Opin Oncol. 1996. PMID: 8868093 Review.

3

PML/RAR alpha rearrangement in acute promyelocytic leukaemia with t(1;17) elucidated using fluorescence in situ hybridization.

Eclache V, Benzacken B, Le Roux G, Casassus P, Chomienne C. Eclache V, et al. Among authors: chomienne c. Br J Haematol. 1997 Aug;98(2):440-3. doi: 10.1046/j.1365-2141.1997.2253042.x. Br J Haematol. 1997. PMID: 9266946 Free article.

4

Submicroscopic insertion of RARalpha gene into chromosome 15 in two cases of acute promyelocytic leukemia.

Viguié F, Aboura A, Ramond S, Bouscary D, Baudard M, Chomienne C, Marie JP. Viguié F, et al. Among authors: chomienne c. Cancer Genet Cytogenet. 2000 Jun;119(2):162-4. doi: 10.1016/s0165-4608(99)00232-0. Cancer Genet Cytogenet. 2000. PMID: 10867154

5

Future perspectives for acute promyelocytic leukemia therapy.

Cassinat B, Chomienne C. Cassinat B, et al. Among authors: chomienne c. Semin Hematol. 2001 Jan;38(1):86-91. doi: 10.1016/s0037-1963(01)90008-3. Semin Hematol. 2001. PMID: 11172542 Review.

6

Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.

Cassinat B, Guillemot I, Moluçon-Chabrot C, Zassadowski F, Fenaux P, Tournilhac O, Chomienne C. Cassinat B, et al. Among authors: chomienne c. Haematologica. 2006 Dec;91(12 Suppl):ECR58. Haematologica. 2006. PMID: 17194664

7

When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).

Cassinat B, de Botton S, Kelaidi C, Ades L, Zassadowski F, Guillemot I, Schlageter MH, Raffoux E, Harousseau JL, Legrand O, Escoffre-Barbe M, Reman O, Gardembas M, Himberlin C, Cahn JY, Guyotat D, Bouscary D, Parry A, Rousselot P, Baruchel A, Dombret H, Chevret S, Fenaux P, Chomienne C. Cassinat B, et al. Among authors: chomienne c. Leuk Res. 2009 Sep;33(9):1178-82. doi: 10.1016/j.leukres.2008.12.010. Epub 2009 Jan 23. Leuk Res. 2009. PMID: 19167754

8

Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.

Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Adès L. Bally C, et al. Among authors: chomienne c. J Clin Oncol. 2012 May 10;30(14):1641-6. doi: 10.1200/JCO.2011.38.4560. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473162 Clinical Trial.

9

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. Castaigne S, et al. Among authors: chomienne c. Blood. 1990 Nov 1;76(9):1704-9. Blood. 1990. PMID: 2224119 Free article. Clinical Trial.

10

Retinoid differentiation therapy in promyelocytic leukemia.

Chomienne C, Fenaux P, Degos L. Chomienne C, et al. FASEB J. 1996 Jul;10(9):1025-30. doi: 10.1096/fasebj.10.9.8801163. FASEB J. 1996. PMID: 8801163 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters